Roifman-Chitayat Syndrome

Roifman-Chitayat syndrome (often shortened to ROCHIS) is a combined primary immunodeficiency. “Combined” means both the antibody-producing (B-cell) and T-cell parts of the immune system do not work normally. Because of this, people get repeated infections with bacteria, viruses, and fungi. At the same time, the syndrome also causes structural changes in the face, eyes, brain, bones, and sometimes other organs. [1] Children with this syndrome usually have developmental delay, problems with movement such as poor muscle tone or ataxia (unsteady walking), and sometimes seizures. Many have optic nerve atrophy, which means damage to the nerve that carries visual signals from the eye to the brain, leading to poor vision. They also often have short bones in the hands and feet, cone-shaped bone ends (epiphyses), and low bone density (osteopenia). [1][2]

Roifman-Chitayat syndrome (also called combined immunodeficiency with facio-oculo-skeletal anomalies) is an autosomal-recessive combined immunodeficiency. Children inherit faulty copies of two genes from both parents. They have serious immune problems plus typical facial features, eye (optic nerve) damage, bone changes, and global developmental delay.

In this syndrome, the immune system cannot fight bacteria, viruses, and fungi properly, so patients get repeated, sometimes severe infections like pneumonia, ear infections, sinus infections, and unusual or opportunistic infections. Because the bones, eyes, and brain also develop abnormally, children are often short, have motor and speech delay, unsteady walking, and vision problems from optic nerve atrophy or retinal damage.

Roifman-Chitayat syndrome is related but not identical to Roifman syndrome, which is caused by mutations in the non-coding gene RNU4ATAC that disrupt minor intron splicing and lead to skeletal dysplasia, retinal dystrophy, and antibody deficiency. Both conditions share some features (growth retardation, bone changes, immune problems), but Roifman-Chitayat has a broader combined immunodeficiency and different gene defects.

The condition was first described in 2009 by Dr. Chaim Roifman and Dr. David Chitayat, who reported children from one family with this special pattern of immune problems, facial features, bone changes, and neurologic problems. Since then, only very few patients have been reported worldwide, so Roifman-Chitayat syndrome is considered ultra-rare. [2]

---

Other names

Doctors and researchers may use different names for this condition. These names all point to the same disorder or very closely related descriptions: [3]

• Combined immunodeficiency with facio-oculo-skeletal anomalies

• Combined immunodeficiency with faciooculoskeletal anomalies

• Roifman-Chitayat syndrome (ROCHIS)

• Immuno-osseous dysplasia with facio-oculo-skeletal anomalies

All of these names describe the main features:

• “Combined immunodeficiency” – both B-cell and T-cell immune functions are affected.

• “Facio” – the face has characteristic features like high forehead, wide-set eyes, and flat nasal bridge.

• “Oculo” – the eyes are involved, often with optic nerve atrophy and sometimes other visual problems.

• “Skeletal” or “osseous” – bones of the hands, feet, and sometimes spine or other areas show structural changes. [3][4]

The syndrome is classified as:

• A primary immunodeficiency due to adaptive immunity defects (disorder of T- and B-cell signaling).

• An autosomal recessive digenic disorder, meaning a child must inherit abnormal copies of two different genes from the parents to show the full syndrome. [4]

It is important not to confuse Roifman-Chitayat syndrome with Roifman syndrome or Roifman-Melamed syndrome (now called spondyloenchondrodysplasia). These are different genetic conditions, with different genes and slightly different patterns of symptoms. [5]

---

Types of Roifman-Chitayat syndrome

Because very few patients have been reported, there is no strict official “type” classification. However, based on published case descriptions, doctors sometimes think about clinical patterns or “forms” of the disease. These are practical groupings, not formal subtypes: [6]

• Typical combined immunodeficiency form – prominent recurrent infections plus the facial, eye, bone, and developmental features.

• Neurologic-dominant form – strong neurologic features such as seizures and ataxia, with obvious developmental delay, but infections may be less frequent.

• Skeletal-dominant form – clear bone abnormalities in hands, feet, and spine, with milder immune or neurologic problems.

• Severe early-onset form – symptoms appear soon after birth with serious infections, failure to grow, and marked neurologic problems.

• Milder late-diagnosed form – subtle physical features and moderate immunodeficiency that are recognized only later in childhood when infections and school difficulties become noticeable.

These “types” help clinicians think about the different ways the syndrome can show itself, but they are all caused by the same basic genetic mechanism and are part of one disease spectrum. [6][7]

---

Causes and risk factors

The main cause of Roifman-Chitayat syndrome is a problem in specific genes that are important for immune signaling and cell division. All other “causes” below are really different aspects or consequences of this single genetic defect or factors that make it more likely to appear in a family. [1]

1. Loss-of-function mutations in the PIK3CD gene – PIK3CD encodes the p110δ catalytic subunit of PI3K, a key signaling protein in immune cells. Harmful variants can reduce or change PI3K-δ function and disturb both B-cell and T-cell responses, leading to combined immunodeficiency and abnormal development of several tissues. [1][2]

2. Loss-of-function mutations in the KNSTRN gene – KNSTRN (also called SKAP or kinetochore-associated protein) helps chromosomes attach correctly during cell division. Damaging variants may disturb normal division and development of rapidly growing tissues such as brain, bone, and immune cells. [2]

3. Combined digenic defect (PIK3CD plus KNSTRN) – Roifman-Chitayat syndrome is special because both genes are affected together. Losing function in both pathways appears to be necessary to produce the full pattern of immune, facial, eye, and skeletal features. [3]

4. Autosomal recessive inheritance – The condition follows an autosomal recessive pattern, meaning a child must receive one non-working copy of each gene from both parents. Each parent is usually a healthy carrier with one working and one non-working copy. [3][4]

5. Consanguinity (parents related by blood) – In the original family, the parents were related (consanguineous). When parents are related, they are more likely to share the same rare gene changes, so their children have a higher chance of inheriting two non-working copies and developing the syndrome. [4]

6. Loss of PI3K-Akt signaling balance – The PIK3CD gene participates in the PI3K-Akt signaling pathway, which controls cell survival, growth, and metabolism. When this pathway is disturbed, immune cells, brain cells, and bone cells may not develop or function normally. [5]

7. Disrupted T-cell receptor (TCR) and B-cell receptor (BCR) signaling – PI3K-δ is important for signals that activate T and B cells after they meet germs. Faulty signaling causes weak immune responses, leading to recurrent infections and poor antibody responses. [6]

8. Abnormal kinetochore-microtubule interaction – KNSTRN helps align chromosomes during cell division at the kinetochore. Errors here can cause subtle problems in brain and skeleton development and may contribute to the typical facial and skeletal anomalies. [7]

9. Reduced immune cell numbers or function – The combined gene defects can lead to low levels or poor function of T cells, B cells, or their subsets. This cellular immunodeficiency is a direct cause of vulnerability to infections. [7][8]

10. Impaired antibody production – Some patients show reduced ability to make specific antibodies after vaccines or infections. This is another direct mechanism behind recurrent bacterial infections such as pneumonia or sinusitis. [8]

11. Abnormal brain development – Because the genes also act in neural tissue, their disruption can alter brain development, leading to delayed milestones, ataxia, seizures, or structural changes seen on brain imaging. [9]

12. Defects in optic nerve development – The optic nerve is part of the central nervous system and can be damaged when neural development is disturbed, leading to optic atrophy and vision loss. [9][10]

13. Disordered bone growth plates (epiphyses) – Skeletal anomalies such as cone-shaped epiphyses and shortened metacarpals/metatarsals may result from cell division errors and altered signaling in growing bone, which trace back to the underlying genes. [10]

14. Low bone density (osteopenia) – Disturbed bone remodeling due to signaling abnormalities can lead to reduced bone mineral density, increasing the risk of fractures or bone pain. [10][11]

15. Abnormal facial bone and soft tissue patterning – The characteristic facial features (high forehead, broad nasal root, thin lips, square chin) arise from subtle changes in craniofacial bone growth and soft tissue development linked to the genetic defects. [11]

16. Increased susceptibility to respiratory infections – The combined immune problem directly causes frequent infections of the lungs and airways, such as pneumonia and bronchitis. These infections are not the original cause of the syndrome, but they are a major result of the genetic immune defect. [12]

17. Possible genetic founder effects in certain populations – Since reported families are few and often from related parents or specific communities, a rare mutation may have been passed down through generations, increasing disease risk in that group. [12][13]

18. Random new (de novo) mutations – In theory, some cases could arise from new mutations in PIK3CD or KNSTRN in the egg or sperm or early embryo, even if the parents are not carriers. For ultra-rare diseases, this possibility is always considered, though it has not been clearly described in all cases yet. [13]

19. Modifier genes and background genetic factors – Other genes in the child’s genome may slightly modify how severe the syndrome becomes. These modifiers do not cause the disease alone but may influence how strong the symptoms appear. [13][14]

20. Environmental triggers acting on an already weak immune system – Once the genetic defect exists, everyday environmental germs or infections can reveal or worsen the clinical picture. For example, common viruses or bacteria may cause unusually severe disease because the immune system cannot respond properly. [14]

---

Symptoms and clinical features

People with Roifman-Chitayat syndrome can have many different symptoms. Not every person has all of them, but the combination of several features makes doctors think about this diagnosis. [1]

1. Recurrent infections – Children often have repeated infections such as pneumonia, bronchitis, sinus infections, or ear infections. These infections may be more severe, last longer, or come back more often than in other children because the immune system is weak. [1][2]

2. Combined immunodeficiency signs – Blood tests often show problems in both T- and B-cell function. Clinically, this may show as poor response to vaccines, unusual or opportunistic infections, or slow recovery from common illnesses. [2]

3. Developmental delay – Many children reach milestones like sitting, walking, and talking later than usual. They may also have difficulties with learning, problem solving, and communication. These delays reflect the effect of the syndrome on brain development. [3]

4. Hypotonia (low muscle tone) – Babies may feel “floppy” when held, and older children may seem weak or tire easily. Low tone can make it harder for them to sit, stand, or walk on time. [3][4]

5. Cerebellar ataxia (unsteady movements) – Some children have trouble coordinating their movements. They may walk with a wide-based, unsteady gait, have difficulty with fine tasks like buttoning clothes, or appear clumsy. This is linked to problems in parts of the brain that control balance. [4]

6. Myoclonic seizures or other seizure types – Sudden jerking movements (myoclonus) or other seizure patterns may occur. These are signs of abnormal electrical activity in the brain and require neurologic evaluation. [5]

7. Optic nerve atrophy and visual problems – Damage to the optic nerve causes pale optic discs on eye exam and can reduce visual acuity. Some children may have poor vision, difficulty tracking objects, or may bump into things. [5][6]

8. Facial dysmorphism – Typical facial features include a high or prominent forehead, broad nasal root and flat nasal bridge, thin lower lip, sometimes the upper lip overlapping the lower, and a square or boxy chin. The eyes may be wide-set (hypertelorism), and there may be mild eyelid swelling. [6]

9. Skeletal anomalies of hands and feet – X-rays show shortened metacarpal and metatarsal bones and cone-shaped epiphyses. Clinically, hands and feet may look short or broad, and joints may be somewhat stiff or painful over time. [7]

10. Osteopenia (low bone density) – Bones may be less dense and more fragile. This can increase the risk of fractures or bone pain, especially after falls or minor injuries. [7][8]

11. Short stature or growth delay – Some children have slower growth in height and weight, leading to stature below average for age. This may reflect both underlying disease and frequent illness. [8]

12. Abnormalities of other organs – A few reported patients have had issues like umbilical hernias, ectopic kidney, or mild digestive system abnormalities, showing that the syndrome can affect several internal organs. [9]

13. Respiratory problems – Because of repeated lung infections, children may develop chronic cough, wheezing, or reduced exercise tolerance. In severe cases, long-term lung damage can occur. [9][10]

14. Behavioral or cognitive difficulties – Some children may have attention problems, learning difficulties, or social challenges related to their developmental and neurologic issues. These may affect school performance and daily life. [10]

15. General fatigue and reduced stamina – Ongoing immune problems, infections, and neurologic signs often make children tire more easily than their peers, limiting sports and active play. [11]

---

Diagnostic evaluation and tests

Because Roifman-Chitayat syndrome is very rare and complex, diagnosis usually happens in a specialized center. The evaluation includes a careful physical exam, detailed history of infections and development, and many tests. Below are 20 important tests, grouped into physical exam, manual/bedside tests, lab and pathological tests, electrodiagnostic tests, and imaging tests. [1]

---

Physical examination tests

1. General physical examination – The doctor looks at the child’s overall appearance, growth (height, weight, head size), skin, muscles, joints, and posture. They note signs like short stature, low muscle tone, abnormal gait, or visible deformities. This broad view helps the doctor suspect a syndromic cause rather than a simple, isolated problem. [1]

2. Dysmorphology (face and skull) assessment – A clinical geneticist carefully studies facial features: forehead shape, eye spacing, nasal bridge, lips, chin, and head shape. In Roifman-Chitayat syndrome, the pattern of high forehead, wide-set eyes, flat nasal bridge, and square chin can strongly suggest the diagnosis when combined with immunodeficiency. [2]

3. Musculoskeletal examination of limbs and spine – The doctor examines the hands, feet, arms, legs, and spine for abnormal length, joint range of motion, and deformities. Short fingers or toes, broad hands or feet, or spine curvature may reflect the underlying skeletal changes. [3]

4. Neurologic physical examination – This includes checking muscle tone, strength, reflexes, coordination, and balance. Signs of hypotonia, ataxia, or abnormal reflexes indicate involvement of the nervous system and support the idea of a multisystem genetic syndrome. [4]

---

Manual and bedside tests

5. Developmental milestone assessment – Using simple questions and observations, clinicians check when the child started sitting, standing, walking, talking, and using hands. They may use standardized developmental checklists. Delays across several areas suggest a global developmental problem rather than isolated learning or motor issues. [5]

6. Coordination and gait testing – The child may be asked to walk in a straight line, stand with feet together, touch finger to nose, or perform other simple tasks. Difficulty with these tasks, especially with a wide-based or wobbly gait, points toward cerebellar ataxia or other neurologic involvement seen in this syndrome. [6]

7. Simple vision and eye movement screening – At the bedside, doctors can check if the child can follow a moving object, recognize pictures or letters, and move the eyes smoothly in all directions. Reduced visual function or abnormal eye movements raise suspicion for optic nerve or brain involvement, which fits with Roifman-Chitayat syndrome. [7]

8. Basic respiratory function check – The doctor listens to the lungs with a stethoscope and may perform simple breathing tests if age-appropriate (such as blowing into a device). Repeated crackles, wheezes, or reduced breath sounds suggest chronic lung disease from recurrent infections. [8]

---

Laboratory and pathological tests

9. Complete blood count (CBC) – This test measures red blood cells, white blood cells, and platelets. In Roifman-Chitayat syndrome, total white cell counts may be normal or mildly abnormal, but detailed patterns can show lymphocyte issues. The CBC helps rule out other causes of infections and guides further immunologic tests. [9]

10. Quantitative immunoglobulin levels (IgG, IgA, IgM, IgE) – Measuring the main antibody classes helps detect humoral immune defects. Some patients have low levels or abnormal patterns, which explain poor responses to infections and vaccines and support the diagnosis of combined immunodeficiency. [10]

11. Lymphocyte subset analysis (flow cytometry) – This test counts different types of lymphocytes (T cells, B cells, NK cells) and their subgroups. Abnormal numbers or proportions show which parts of the immune system are most affected and help distinguish Roifman-Chitayat syndrome from other primary immunodeficiencies. [11]

12. Functional T-cell and B-cell tests – Laboratory tests can measure how T cells respond to stimuli (mitogens) and how B cells produce antibodies to vaccines or test antigens. Poor responses confirm that not only the numbers but also the function of these cells is impaired. [12]

13. Genetic testing for PIK3CD and KNSTRN – Targeted gene sequencing or gene panels for primary immunodeficiency look directly for harmful variants in PIK3CD and KNSTRN. Finding disease-causing changes in both genes in a child with the typical clinical picture confirms the diagnosis of Roifman-Chitayat syndrome. [13]

14. Broader exome or genome sequencing – If targeted testing is negative but suspicion remains high, whole exome or genome sequencing can be used to identify rare or new variants in these or related genes. In ultra-rare diseases with few known cases, this approach can also discover new information about the condition. [14]

---

Electrodiagnostic tests

15. Electroencephalogram (EEG) – An EEG records the electrical activity of the brain. In children with seizures or suspected myoclonus, the EEG helps confirm seizure activity, classify the type, and guide treatment. Abnormal EEG findings support the presence of a structural or functional brain problem that is part of the syndrome. [15]

16. Nerve conduction studies and electromyography (EMG) – In selected patients with marked hypotonia or weakness, these tests check the health of peripheral nerves and muscles. While not required for every case, they help rule out other neuromuscular disorders and show whether the low tone is mainly central (brain-related) or peripheral. [16]

17. Visual evoked potentials (VEP) – VEP tests measure the brain’s response to visual stimuli and help quantify how well the optic nerves work. In Roifman-Chitayat syndrome, VEP may show delayed or reduced responses, matching the optic nerve atrophy seen in eye exams and imaging. [17]

---

Imaging tests

18. Brain MRI – Magnetic resonance imaging gives detailed pictures of the brain and cerebellum. It may show structural abnormalities or volume loss in regions that control balance, coordination, or vision pathways. These findings, together with seizures or ataxia, strengthen the diagnosis of a neuro-immunologic genetic syndrome like Roifman-Chitayat. [18]

19. Skeletal survey and limb X-rays – X-rays of the hands, feet, long bones, and spine reveal short metacarpals/metatarsals, cone-shaped epiphyses, and osteopenia. This pattern of bone changes is typical for the syndrome and helps distinguish it from other immunodeficiencies without skeletal anomalies. [19]

20. Ophthalmologic imaging (fundus photography and OCT) – Detailed pictures of the retina and optic nerve, often with optical coherence tomography (OCT), can show thinning and pallor of the optic nerve head. These objective findings confirm optic atrophy and help monitor vision over time in affected children. [20]

Non-pharmacological treatments

Below are 20 important non-drug measures used to support people with Roifman-Chitayat syndrome. These do not replace medicines but work together with them.

1. Individualized infection-avoidance education
   Families are taught in very simple language how infections spread and how to reduce exposure at home, school, and hospital. This includes handwashing, avoiding sick contacts, masking in crowded places during outbreaks, and careful food and water safety. For people with combined immunodeficiency, these steps can dramatically lower the number of serious infections and hospital visits.

2. Vaccination planning (modified schedule)
   Patients usually follow a special vaccine plan: most inactivated vaccines are encouraged, but live vaccines may be avoided or delayed depending on immune function. The goal is to protect against vaccine-preventable infections while staying safe. The immunology team interprets blood tests, considers family exposure risks, and then writes a personalized vaccination schedule.

3. Early treatment action-plan for infections
   Families receive written instructions about what to do when fever, cough, diarrhea, or skin infections begin. They learn which symptoms mean “call the doctor now” and which mean “go straight to emergency.” Quick contact with clinicians and rapid testing often prevent a mild problem from turning into sepsis or respiratory failure.

4. Regular pulmonary (lung) physiotherapy
   Because recurrent chest infections can lead to bronchiectasis, many teams teach daily breathing exercises, airway-clearance techniques, and, when needed, use of oscillating devices or chest physiotherapy. This non-drug support helps move mucus out of the lungs, reduces bacterial load, and maintains better long-term lung function.

5. Physical therapy for motor delay and hypotonia
   Children with Roifman-Chitayat syndrome often have low muscle tone, unstable gait, and delayed gross-motor milestones. Physical therapists design play-based exercises that strengthen muscles, improve balance, and train safe walking or wheelchair use. This reduces falls, improves independence in daily activities, and supports bone health by encouraging weight-bearing.

6. Occupational therapy for fine-motor and daily skills
   Occupational therapists help children learn how to dress, feed themselves, write, and use tools despite hand weakness, tremor, or skeletal differences. They may recommend adapted cutlery, pencil grips, or computer access. The aim is to maximize school participation and reduce frustration in everyday tasks.

7. Speech and language therapy
   Developmental and cognitive delays are common, and speech therapists are key members of the team. They assess understanding, speech clarity, swallowing safety, and communication style. Therapy may focus on simple language practice, use of pictures or communication boards, and safe eating techniques to reduce choking risk and improve nutrition.

8. Low-vision rehabilitation and assistive devices
   Optic nerve atrophy and retinal problems can cause progressive vision loss. Low-vision specialists provide magnifiers, high-contrast materials, large-print books, and technology such as screen readers. Training in how to use these tools can greatly improve school achievement and independence even when vision is limited.

9. Educational support and special schooling
   Because many patients have learning difficulties, neuropsychological testing and individualized education plans (IEPs) are often needed. Teachers, psychologists, and therapists work together to adapt curriculum, give extra time, use visual aids, and create realistic academic goals. This improves quality of life and reduces anxiety for both child and family.

10. Orthopedic bracing and postural support
    Skeletal anomalies and spinal or hip deformities can cause pain and mobility limits. Orthopedic teams may use braces, orthotics, or customized seating systems. These supports help align the spine and limbs, reduce contractures, and delay or complement surgical interventions.

11. Nutritional counselling and growth monitoring
    Dietitians help families plan high-nutrient meals that are safe for an immunocompromised child (for example, avoiding unpasteurized products and undercooked foods). They track growth charts, suggest calorie supplements if needed, and coordinate with doctors when tube feeding or special formulas are required to maintain weight and muscle mass.

12. Psychological and family counselling
    Living with a chronic rare disease can cause stress, anxiety, and depression in patients and caregivers. Psychologists provide coping strategies, support groups, and behavioural therapy to manage fears about infections, hospital stays, and future disability. Addressing mental health improves adherence to treatment and overall family functioning.

13. Genetic counselling for families
    Because the condition is autosomal recessive, parents are usually carriers and there may be a risk in future pregnancies. Genetic counsellors explain inheritance patterns, recurrence risks, and options such as carrier testing of relatives or prenatal testing, when available. This helps families make informed reproductive decisions.

14. Home-care coordination and nursing support
    Some patients need home infusions, oxygen, feeding tubes, or complex medication schedules. Specialised nurses and case managers coordinate supplies, teach families how to use equipment safely, and monitor for early signs of complications. This team-based, non-pharmacologic support reduces emergency visits and improves quality of life.

15. Respiratory vaccination of household contacts (“cocooning”)
    When live vaccines are unsafe for the patient, vaccinating family members and close contacts against influenza, COVID-19, whooping cough, and other respiratory infections can indirectly protect them. This “cocoon” strategy lowers the chance that pathogens enter the home in the first place.

16. Environmental control at home
    Simple changes like good ventilation, avoiding tobacco smoke, reducing mould and dampness, and controlling dust and indoor pollutants can help protect fragile lungs. Families may also use air filters or humidifiers when advised. These steps are especially helpful for patients who already have lung damage from prior infections.

17. Safe physical activity and adaptive sports
    Even with skeletal problems or weakness, gentle regular exercise within the patient’s limits supports cardiovascular fitness, bone strength, and mood. Physical therapists and doctors guide safe activities (for example, swimming with supervision, cycling with adapted bikes, or gentle stretching) and warn against high-risk contact sports if fractures are a concern.

18. Sleep hygiene and fatigue management
    Chronic illness and frequent infections can disturb sleep and cause severe fatigue. Non-drug measures include regular bedtimes, limiting late-evening screens, treating breathing problems like obstructive sleep issues, and pacing daytime activities. Good sleep supports immune function and mental health.

19. Social-care and disability support services
    Many families qualify for disability benefits, home-help services, or transportation assistance. Social workers help with paperwork, school rights, and connecting families to rare-disease networks. These non-medical supports reduce financial strain and isolation, which are common in rare chronic conditions.

20. Participation in rare-disease registries and research
    Because very few patients are known worldwide, enrolling in registries or observational studies helps researchers understand natural history and treatment responses. Families gain better access to expert centres and may learn about new therapies earlier, while their data helps improve care guidelines for future patients.

---

Drug treatments

Very important safety note: All medicines below are prescription drugs. Doses, timing, and combinations must be decided by specialist doctors; this list is for educational understanding of what teams may use in Roifman-Chitayat syndrome, based on experience with similar combined immunodeficiencies.

1. Intravenous immune globulin (IVIG)
   IVIG is a purified mixture of antibodies from healthy donors. It is a standard treatment for many primary immunodeficiencies to reduce serious infections. It is given through a vein at regular intervals (often every 3–4 weeks) in a hospital or infusion center. Multiple products are licensed by the FDA for primary immunodeficiency, and labels describe indications, infusion rates, and important risks like infusion reactions, kidney problems, and blood clots.

2. Subcutaneous immune globulin (SCIG)
   SCIG uses similar antibody preparations but delivered under the skin, often at home after training. Smaller, more frequent doses (for example weekly) keep antibody levels steady and can improve quality of life. Clinical studies show SCIG is effective for primary immunodeficiency with a side-effect profile that is mainly local (redness or swelling at infusion sites).

3. Broad-spectrum oral antibiotics (e.g., amoxicillin, amoxicillin-clavulanate)
   Common oral antibiotics like amoxicillin or amoxicillin-clavulanate are used to treat bacterial respiratory or ear infections in immunodeficient patients. FDA labels explain that these drugs treat infections caused by susceptible bacteria and warn about allergic reactions, diarrhea, and the risk of resistant organisms if overused. In Roifman-Chitayat syndrome, they are often used early and aggressively to prevent complications.

4. Trimethoprim-sulfamethoxazole (co-trimoxazole; Bactrim/Sulfatrim)
   This combination antibiotic is widely used in primary immunodeficiency both to treat infections and as prophylaxis against Pneumocystis jirovecii pneumonia (PJP) or recurrent bacterial infections when T-cell function is poor. The FDA label emphasizes that it should be reserved for proven or strongly suspected bacterial infections or prophylactic indications, and it lists serious possible side effects such as severe skin reactions, bone-marrow suppression, and kidney issues.

5. Macrolide antibiotics (e.g., azithromycin, clarithromycin)
   Macrolides may be used in some patients for treatment or prophylaxis of respiratory infections. FDA-approved labels for these drugs describe their use in bacterial sinusitis, pneumonia, and other infections as well as side effects like stomach upset, liver enzyme changes, and rare heart-rhythm problems. In immunodeficient patients, macrolides must be chosen carefully to avoid drug interactions.

6. Antifungal agents (e.g., fluconazole – Diflucan)
   Combined immunodeficiency can predispose to fungal infections of the mouth, lungs, blood, or urinary tract. Fluconazole is an oral and intravenous antifungal approved to treat Candida infections and cryptococcal meningitis. FDA labeling lists uses, liver toxicity warnings, important drug interactions (for example with certain heart-rhythm or seizure medicines), and storage instructions.

7. Antiviral drugs (e.g., acyclovir; valacyclovir)
   Reactivations of herpes viruses (like HSV or VZV) may be more severe in immunodeficient patients. Acyclovir tablets and capsules are FDA-approved antiviral medicines which inhibit viral DNA replication and are used for herpes simplex and varicella-zoster infections. Labels highlight kidney safety (need for good hydration), neurological side effects, and dosing adjustments in kidney disease.

8. Inhaled bronchodilators (e.g., salbutamol/albuterol)
   When recurrent infections cause chronic lung disease with wheeze or airflow limitation, inhaled bronchodilators can open the airways and ease breathing. Official product information notes that these drugs relax smooth muscle in the airways and are used in asthma and reversible bronchospasm, with side effects like tremor and fast heart rate. They are supportive rather than disease-modifying.

9. Inhaled or short courses of systemic corticosteroids
   Corticosteroids reduce inflammation in the lungs or other tissues but can further suppress immunity if overused. In Roifman-Chitayat syndrome, they may be used in short bursts for severe airway inflammation, auto-immune complications, or after transplant procedures. FDA labels for various corticosteroids emphasise risks such as infection, adrenal suppression, bone thinning, and growth delay.

10. Immunomodulatory steroids for auto-immunity
    Some patients with combined immunodeficiency develop auto-immune disease (for example cytopenias). Prednisone and similar agents can be used for induction of remission. Clinical guidelines stress careful tapering and monitoring for side effects like weight gain, mood changes, high blood pressure, and diabetes.

11. Granulocyte-colony stimulating factor (G-CSF) in selected cases
    If neutrophil counts are severely reduced or infections are unusually severe, G-CSF may be used to stimulate production of neutrophils in the bone marrow. Product labels for G-CSF show indications for congenital or acquired neutropenia and chemotherapy-induced neutropenia, mechanism (binding to G-CSF receptors on precursors), and side effects like bone pain and splenic enlargement.

12. Prophylactic antibiotics for recurrent infections
    Beyond short-term treatment, some patients receive low-dose, long-term antibiotics to prevent repeated infections. Recent trials in hypogammaglobulinemia and international guidelines discuss when to choose prophylactic antibiotics versus immunoglobulin replacement, weighing infection reduction against resistance and side effects.

13. Antipyretics and analgesics (e.g., paracetamol/acetaminophen)
    While not disease-specific, paracetamol is often used to control fever and pain from infections or infusions. Labels explain liver toxicity risk at high doses and the importance of not combining multiple paracetamol-containing products. In rare diseases, doctors stress that fever should never be masked without also looking for its cause.

14. Vitamin D and calcium supplements (medical-grade)
    Because skeletal anomalies and reduced mobility can weaken bones, supervised vitamin D and calcium supplements may be prescribed to reach recommended blood levels, especially if sun exposure is low. Professional guidelines on bone health in chronic disease warn against excessive dosing, which can harm kidneys and the heart.

15. Proton-pump inhibitors or H2 blockers (for GI side-effects)
    Patients taking multiple antibiotics or steroids may develop gastritis, reflux, or ulcers. Acid-reducing drugs protect the stomach and are widely used in complex medical regimens. FDA labels mention indications for ulcer healing and reflux, along with risks like nutrient malabsorption or infections such as C. difficile when used long-term.

16. Anti-seizure medications
    Some patients have seizures or movement disorders. Standard anti-epileptic drugs are chosen depending on seizure type and possible interactions with antibiotics, antifungals, and immunosuppressants. Labels stress gradual titration, monitoring for mood changes or liver problems, and avoiding sudden withdrawal.

17. Growth-hormone therapy (selected cases)
    In a few complex immuno-osseous syndromes with proven growth hormone deficiency and safe cancer risk profile, growth-hormone treatment may be considered. Reviews of syndromic immunodeficiencies list growth-hormone pathway defects but emphasise careful risk–benefit analysis and specialist endocrinology input.

18. Low-dose aspirin or anticoagulants (special situations)
    If patients receive IVIG or have other risk factors for blood clots, doctors may use low-dose aspirin or anticoagulants, guided by existing clotting-risk guidelines. This is strictly individualized because both clotting and bleeding risks may be present.

19. Peri-operative antibiotic prophylaxis
    Before orthopedic, eye, or other surgeries, appropriate antibiotics are given around the time of the procedure to prevent surgical-site infections, based on hospital protocols and national guidelines for immunocompromised patients.

20. Experimental or off-label immunomodulatory drugs
    In very rare, severe patients, doctors may consider targeted immunomodulators used in other combined immunodeficiencies, often within research protocols. Because evidence is limited, decisions are individualized and always balanced against infection risk.

---

Dietary molecular supplements

Again, these are medical-grade supplements used under specialist supervision, not over-the-counter self-treatments.

1. Vitamin D (cholecalciferol) – supports bone mineralization and immune modulation; aiming for normal serum levels, not megadoses.

2. Calcium – ensures adequate building blocks for bones, especially if mobility is limited or steroids are used; excess can damage kidneys.

3. Omega-3 fatty acids (fish oil) – studied for anti-inflammatory effects and cardiovascular support; doses are adjusted to avoid bleeding risks when combined with anticoagulants.

4. Protein-rich oral nutrition supplements – boost calorie and protein intake in children with poor appetite or increased needs from chronic illness, helping maintain muscle mass and support immune function.

5. Multivitamin preparations – cover general micronutrient gaps due to poor appetite, restricted diets, or malabsorption, while avoiding overdose of fat-soluble vitamins.

6. Iron (when deficient) – used only if tests show iron-deficiency anemia, to improve energy and growth; given carefully because excess iron can promote infections.

7. Zinc (within recommended limits) – important for normal immune-cell function and wound healing; controlled supplementation can help correct deficiency but high doses may harm copper balance.

8. Probiotics (selected strains, under guidance) – sometimes used to support gut microbiome health, especially during or after antibiotic courses, though evidence in severe immunodeficiency is limited and safety must be carefully assessed.

9. Specialized enteral formulas – for children with feeding difficulties, high-energy or peptide-based formulas may be used via oral or tube feeding to guarantee balanced nutrition.

10. Electrolyte-containing oral rehydration solutions – during diarrheal illness they replace water and salts safely, reducing risk of dehydration and allowing continued absorption of medicines.

---

Immunity-boosting, regenerative and stem-cell–related drugs

1. Hematopoietic stem-cell transplantation (HSCT) conditioning drugs
   In theory, HSCT could partly correct the immune defect by replacing bone-marrow cells. Agents like busulfan and cyclophosphamide are used for conditioning in other combined immunodeficiencies, but HSCT experience in Roifman-Chitayat specifically is extremely limited and such treatment is considered experimental and high-risk.

2. Gene-therapy vectors (research stage)
   Research in severe combined immunodeficiencies is exploring viral vectors that deliver a normal copy of a missing gene into hematopoietic stem cells. While there is no approved gene therapy for Roifman-Chitayat syndrome yet, these approaches provide a model for potential future regenerative treatments.

3. Recombinant growth factors (e.g., G-CSF, erythropoietin)
   These biologic drugs stimulate bone marrow to produce neutrophils or red blood cells. They are sometimes used when cytopenias are present, supporting regeneration of blood cell lines, but must be carefully monitored for side effects and long-term risks.

4. IVIG as functional immune replacement
   Although not regenerative in the genetic sense, IVIG acts as a functional immune booster by supplying pooled antibodies, compensating for the patient’s poor antibody production and reducing infection-related organ damage over time.

5. Subcutaneous immunoglobulin (SCIG) for long-term home-based support
   SCIG supports immune function in a steady way and is sometimes considered a form of chronic “biological replacement therapy”, keeping IgG levels stable and allowing better participation in school and social life.

6. Experimental PI3K-pathway modulators
   Because some Roifman-Chitayat cases involve PIK3CD, there is theoretical interest in drugs that modulate PI3Kδ signalling (already used in other PI3Kδ-related disorders) as future precision therapies. However, these agents can strongly affect immunity and cancer risk, so they are not standard care and remain under study.

---

Surgeries and procedures

1. Orthopedic corrective surgery
   Severe skeletal deformities (for example hip dysplasia, spinal curvature, or limb misalignment) may be treated surgically to improve mobility and relieve pain. Surgeons plan operations carefully around the patient’s immune status, using peri-operative antibiotics and sometimes ICU monitoring.

2. Ophthalmologic surgery or laser procedures
   In some cases, surgery for complications of retinal dystrophy or optic nerve problems may be considered, mainly to preserve remaining vision or treat associated issues like cataracts or retinal detachment. Decisions depend on eye findings and expected benefit relative to anesthesia and infection risks.

3. ENT surgery (ear tubes, sinus surgery)
   Chronic ear infections with fluid build-up or severe sinus disease may require insertion of ventilation tubes or sinus procedures. These interventions improve hearing, reduce infection frequency, and support language development, but require careful infection control in the operating theatre.

4. Feeding-tube placement (gastrostomy)
   If oral intake is not enough to support growth or is unsafe due to swallowing difficulties, a gastrostomy tube can be placed surgically or endoscopically. This allows reliable nutrition and medication delivery and can transform energy levels and weight gain, though it needs ongoing care to prevent infections.

5. Central venous catheter insertion
   Some patients need long-term venous access for IVIG or other IV therapies. Inserting a central line or port is a surgical procedure that simplifies repeated infusions but carries risks of bloodstream infection and clotting, so strict care protocols are essential.

Prevention and long-term self-care strategies

1. Keep all scheduled immunology and specialist visits.

2. Follow the personalized infection-prevention plan at home and school.

3. Start medical review early when fever, cough, or wound infections appear.

4. Maintain up-to-date, tailored vaccinations where safe.

5. Continue immune-globulin and prophylactic medicines exactly as prescribed.

6. Support nutrition with balanced meals and, when recommended, medical nutrition.

7. Encourage safe physical activity and regular physiotherapy.

8. Protect lungs with airway-clearance techniques and smoke-free environments.

9. Protect vision with regular eye exams and early reporting of vision changes.

10. Support mental health with counselling, peer support, and school accommodations.

---

When to see a doctor or seek emergency care

Caregivers should have clear instructions from their team, but generally immediate medical review is needed for: high fever, breathing difficulty, fast breathing, chest pain, very low energy, confusion, seizures, or signs of dehydration (no urine, dry mouth, sunken eyes). Persistent ear pain, sinus pain, cough, or diarrhoea that does not improve over a few days should trigger early clinic review, because delaying care in combined immunodeficiency can lead quickly to serious complications.

Families should also contact their team before travel, surgery, or dental procedures, because antibiotic prophylaxis, vaccination checks, or extra IVIG doses might be needed. Any sudden change in walking, behaviour, vision, or seizures also deserves urgent evaluation, as these may reflect neurological or eye complications of the syndrome.

---

What to eat and what to avoid

People with Roifman-Chitayat syndrome benefit from a balanced, safe diet that supports growth and immune function. In general, doctors and dietitians recommend regular meals with enough calories, high-quality protein (such as eggs, fish, poultry, beans), whole grains, fruits, and vegetables. Foods rich in vitamin D, calcium, and other micronutrients help support bone health, especially when mobility is limited. Clean, well-cooked food and safe drinking water are very important to reduce infection risk.

Usually they advise to avoid raw or undercooked meat, raw eggs, unpasteurized milk or cheese, and unwashed raw vegetables in settings where water safety is uncertain. Street food and buffet food held at room temperature for long periods may also be risky. Unnecessary “immune booster” supplements and herbal mixtures sold without regulation should be avoided because they may interact with medicines or suppress immunity. Any diet changes or supplements should be discussed with the medical team first.

---

Frequently asked questions

1. Is there a cure for Roifman-Chitayat syndrome?
At present there is no treatment that fixes the underlying genetic problem. Care focuses on preventing infections, protecting organs, and supporting development. Research in gene therapy and stem-cell transplantation for related combined immunodeficiencies may offer future options, but these are not yet standard for this condition.

2. Will every child with this syndrome have the same symptoms?
No. Roifman-Chitayat syndrome is very variable. Some children have severe infections and major developmental disability; others have milder problems. Even brothers and sisters with the same genes can show different patterns. That is why treatment plans must be personalized.

3. Why are infections such a big concern?
Because the immune system does not work properly, common germs that are mild for other children can cause serious or repeated infections here. Each infection risks lung scarring, hearing loss, vision problems, or sepsis. Immunoglobulin replacement, prophylactic antibiotics, and strong non-drug prevention help lower this risk.

4. Why is immunoglobulin replacement so important?
Immunoglobulin (IVIG or SCIG) provides ready-made antibodies that the body cannot make in enough quantity. Studies in primary immunodeficiency, and specific reports in Roifman syndrome, show that regular immunoglobulin therapy reduces serious infections and hospitalizations and improves long-term lung function.

5. Can my child have live vaccines?
This depends on the exact immune defect and test results. Some live vaccines may be unsafe if T-cell function is low. The immunology team will decide which vaccines are recommended and which should be avoided or delayed. Household members are often encouraged to be fully vaccinated to protect the child.

6. Will my child be able to go to school?
Many children with Roifman-Chitayat syndrome attend school with supports. They may need special education plans, physical or speech therapy, and adjustments such as shorter days, reduced class size, or extra infection-prevention measures. Early coordination with teachers and school health staff helps a lot.

7. Can this condition affect adults, or is it only a childhood disease?
It begins in early life, but it is a lifelong condition. Adults can still have infections, lung problems, vision loss, and bone pain. With good care, many individuals reach adulthood, though they may need ongoing support and regular follow-up across multiple specialties.

8. What tests are used to diagnose Roifman-Chitayat syndrome?
Doctors look at clinical features (face, eyes, bones, growth, development) and immune tests (antibody levels, vaccine responses, lymphocyte numbers and function). Final confirmation usually requires genetic testing, which may show combined abnormalities in PIK3CD and KNSTRN, or related pathways.

9. Can parents be tested?
Yes. Because the condition is autosomal recessive, parents are often healthy carriers. Genetic counselling and testing can confirm carrier status and help with planning future pregnancies and informing other family members.

10. Are “immune booster” over-the-counter products helpful?
Most commercial “immune boosters” lack strong scientific evidence and may interact with prescription drugs or even suppress immunity. In serious inherited immunodeficiency, the key treatments are medically supervised immunoglobulin replacement, appropriate antibiotics, vaccines, and non-pharmacological supports—not unregulated supplements.

11. Can diet alone treat this syndrome?
No. A good diet supports general health, but it cannot correct the genetic defect or fully prevent infections. Nutrition is one part of a comprehensive care plan that also includes medicines, therapy, and close monitoring.

12. What is the outlook for a child with Roifman-Chitayat syndrome?
Outlook varies widely. Some children have severe disability and frequent hospital admissions; others function relatively well with support. Early diagnosis, immunoglobulin therapy, prompt infection treatment, and developmental and educational support can all improve long-term outcomes.

13. Can brothers or sisters also have the syndrome?
Yes. Because the condition is inherited in an autosomal-recessive pattern, each pregnancy of carrier parents has a 25% chance of producing an affected child, a 50% chance of another carrier, and a 25% chance of a child who is neither affected nor a carrier. Siblings should be evaluated if there is any concern.

14. How often should my child see the immunology team?
Frequency depends on severity, but many children are seen several times a year, and more often when starting or adjusting treatments like IVIG or prophylactic antibiotics. Extra visits are needed when serious infections, surgeries, or new neurologic or eye problems appear.

15. What is the single most important thing caregivers can do?
The most important step is to build a strong, trusting relationship with a specialist centre experienced in primary immunodeficiency. Following their plan for immunoglobulin therapy, infection prevention, and development support—and asking questions whenever something is unclear—gives the child the best chance for a safer and fuller life.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: February 17 2025.